Hospira Voluntarily Recalls One Lot of Sodium Chloride Product
Hospira, Inc. will initiate a voluntary nationwide recall of one lot of 0.9% sodium chloride injection, USP, 250 mL (NDC 0409-7983-02, Lot 44-002-JT, Expiry 1 AUG 2016) to the user level due to one confirmed customer report of particulate in a single unit. Hospira has identified the particulate as a human hair, sealed in the bag at the additive port area. To date, Hospira has not received reports of any adverse events associated with this issue for this lot.
This lot was distributed nationwide from September 2014 through November 2014. Hospira has initiated an investigation to determine the root cause and corrective and preventive actions.
Source: FDA and Hospira